7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,554.05

+312.73

+0.40%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

LSE - Delayed Quote GBp

Oxford BioDynamics Plc (OBD.L)

0.1075 +0.0020 (+1.90%)

At close: October 30 at 4:25:13 PM GMT

Pilot Study Finds 30-Day Molecular Improvement in Prostate Health Following Intraprostatic Ozone Therapy, Tracked by the EpiSwitch® PSE Blood Test

PR Newswire 9mo ago

OXBOF

Mobilize your Website

View Site in Mobile | Classic

Share by: